Patent details

EP2496707 Title: ENGINEERED ANTI-TSLP ANTIBODY

Basic Information

Publication number:
EP2496707
PCT Application Number:
US2010055062
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP108289646
PCT Publication Number:
WO2011056772
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ENGINEERED ANTI-TSLP ANTIBODY
French Title of Invention:
ANTICORPS ANTI-TSLP MANUFACTURÉ
German Title of Invention:
ENTWICKELTER ANTIKÖRPER GEGEN TSLP
SPC Number:

Dates

Filing date:
02/11/2010
Grant date:
26/02/2020
EP Publication Date:
12/09/2012
PCT Publication Date:
12/05/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/02/2020
EP B1 Publication Date:
26/02/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
02/11/2020
Expiration date:
02/11/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/02/2020
 
 

Name:
Merck Sharp & Dohme Corp.
Address:
126 East Lincoln Avenue, Rahway, NJ 07065-0907, United States (US)

Inventor

Name:
PRESTA, Leonard, G.
Address:
United States (US)

Priority

1

Priority Number:
258051 P
Priority Date:
04/11/2009
Priority Country:
United States (US)

2

Priority Number:
297008 P
Priority Date:
21/01/2010
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/00; C07K 16/24;

Publication

European Patent Bulletin

Issue number:
202009
Publication date:
26/02/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages